Carotid intima-media thickness and anti-phospholipid antibodies in patients with systemic lupus erythematosus

European Journal of Inflammation

Volumn 7, Issue 1, 2009, Pages 19-23

  Rollino, Cristiana ^a   Massara, C ^a   Besso, L ^b   Marcuccio, C ^b   Manganaro, M ^c   Bertero, T ^c   Montaruli, B ^d   Beltrame, G ^a   Ferro, M ^a   Quattrocchio, G ^a   Elia, F ^a   Quarello, F ^a  

^a S GIOVANNI BOSCO HOSPITAL   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c MAURIZIANO HOSPITAL   (Italy)

^d Ospedale Evangelico Valdese   (Italy)

Author keywords

Anti phospholipid antibodies; Atherosclerosis; Intima media thickness; Lupus

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY;

ADULT; AGE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 65549171606     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727x0900700103     Document Type: Article

References (19)

1. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-Mc Williams L, D'Agostino RB, Kuller LH. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145(5):408-15.
2. Aranow C, Ginzler EM. Epidemiology of cardiovascular disease in systemic lupus erythematosus. Lupus 2000; 9:166-9.
3. Frostegård J. Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmun Rev 2202; 1: 233-7.
4. Sherer Y, Shoenfeld Y. Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis? Immunobiology 2003; 207(1):13-16.
5. Petri M. The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort. Thromb Res 2004; 114:593-5.
6. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115:459-67.
7. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002; 20(2):159-69.
8. Roman MJ, Naqvi TZ, Gardin JM, Gerhard-Herman M, Jaff M, Mohler E; American Society of Echocardiography; Society for Vascular Medicine and Biology American society of echocardiography report. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med 2006; 11:201-11.
9. Churg J, Sobin LH. In Renal Disease: Classification and Atlas of Glomerular Disease. Igaku-Shoin: Tokyo, 1982, p 115.
10. Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for Standardization of Lupus Anticoagulants. Thromb Haemost 1991; 5:320-35.
11. Levey AS, Greene T, Kusek JW, Beck GL, MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11:155A.
12. Stein JH, Douglas PS, Srinivasan SR, Bond MG, Tang R, Li S, Chen W, Berenson GS. Distribution and Cross-Sectional Age-Related Increases of Carotid Artery Intima-Media Thickness in Young Adults. The Bogalusa Heart Study. Stroke 2004; 35(12):2782-90.
13. van Leuven SI, Kastelein JJ, D'Cruz DP, Hughes GR, Stroes ES. Atherogenesis in rheumatology. Lupus 2006; 15(3):117-21.
14. Frostegård J. SLE, atherosclerosis and cardiovascular disease. J Intern Med 2005; 257:485-95.
15. Bruce IN. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology 2005; 44(12):1492-502.
16. Sherer Y, Gerli R, Gilburd B, Bartoloni Bocci E, Vaudo G, Mannarino E, Shoenfeld Y. Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies. Lupus 2007; 16(4):259-64.
17. Davidson J, Rotondo D. C-reactive protein: a surrogate marker for atherosclerosis. Curr Opin Lipidol 2004; 15:365-7.
18. Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Pratt JE, Tracy RP, Kuller LH, Manzi S. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthr Rheum 2004; 50:151-9.
19. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349:2399-406.